Results 211 to 220 of about 15,147 (294)

Novel Synthetic Opioids (NSOs) and Their Evolving Crisis: Utilising NPSfinder^® as a Real-Time Predictive Tool. [PDF]

Pharmaceuticals (Basel)
Deligianni E, Arillotta D, Vento A, Corkery JM, Papazisis G, Goulas A, Lione L, Schifano F.   +7 more
europepmc   +1 more source

Beyond the Outburst: Charting a New Frontier for Understanding and Treating Irritability in Autistic Adults

Autism Research, EarlyView.
ABSTRACT Irritability is a prevalent and impairing feature associated with autism, yet remains poorly understood, particularly in adults. Drawing heavily on insights translated from pediatric and transdiagnostic literatures, we propose that irritability in autistic individuals often reflects a psychophysiological stress or threat response, rooted in a ...
Hsiang‐Yuan Lin, Arthur N. Westover, Amy S. F. Lutz, Manish K. Jha   +3 more
wiley   +1 more source

The case against efficiency: friction in social media. [PDF]

Npj Complex
Garland J, Bak-Coleman J, Benesch S, DeDeo S, DiResta R, Eissfeldt J, Ha S, Irons J, Kempes C, Lovato J, Roschke K, Smaldino PE, Stephenson AB, Wheatley T, Semenova V.   +14 more
europepmc   +1 more source

Comparative field‐scale assessment of TLUD and Kon‐Tiki biochar systems: agronomic performance and net CO2e‐based techno‐economics

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract Post‐harvest agricultural residues in Latin America are commonly underutilized, leading to greenhouse gas emissions and lost opportunities for bio‐based value creation. This study tests the hypothesis that decentralized, farmer‐scale pyrolysis technologies can deliver comparable agronomic benefits while exhibiting distinct techno‐economic and ...
Juan F. Saldarriaga, Thomas Käslin, Enara Fernández, Maider Amutio, Gartzen López, Laura Santamaria, Nausika Querejeta, Julián E. López   +7 more
wiley   +1 more source

Suicide Risk and Resilience in Stock Market Investors and Traders: Clinical and Medico-Legal Considerations. [PDF]

Behav Sci (Basel)
Sher L.
europepmc   +1 more source

Operationalizing BioSSbD: A safe‐and‐sustainable‐by‐design framework for biorefineries

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract Biorefineries are central to the transition toward a circular bioeconomy; however, their increasing scale and technological heterogeneity, and the integration of biological, chemical, and thermochemical processes introduce complex challenges related to safety, sustainability, and operational reliability. Existing Safe‐and‐Sustainable‐by‐Design
Fernando Ramonet
wiley   +1 more source

Australia's proposed gambling reforms may be good for industry, but not for public health. [PDF]

Health Promot Int
Thomas S, Pitt H, McCarthy S, Murray M, Daube M.   +4 more
europepmc   +1 more source

From cramming to binge‐watching: Integrating documentary‐based assessment into a pharmacology and toxicology curriculum—a qualitative study

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims In the context of pharmacology and toxicology education, there is a growing shift toward programmatic assessment models that prioritize longitudinal learning, reflection and development of higher‐order cognitive skills. As part of this transition, we are exploring alternative and more meaningful forms of assessment. This qualitative study
Narin Akrawi, Heleen van der Sijs, Floor van Rosse   +2 more
wiley   +1 more source

Reframing Buprenorphine as a Pharmacologic Modifier of Opioid-Induced Respiratory Depression in the Fentanyl Era. [PDF]

Pharmaceuticals (Basel)
Bahji A, Ghauri I, Mathew N, Day N, Tanguay R.   +4 more
europepmc   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source